Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:       

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-133b' Or cancer = '' Total: 41 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-133b bladder cancer down MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.
hsa-mir-133b bladder cancer down MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
hsa-mir-133b breast cancer down MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.
hsa-mir-133b mir-133 breast cancer down Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.
hsa-mir-133b cervical carcinoma up MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.
hsa-mir-133b colorectal cancer up Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-133b colorectal cancer down miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
hsa-mir-133b colorectal cancer down miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer.
hsa-mir-133b colorectal cancer down DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.
hsa-mir-133b esophageal squamous cell carcinoma down miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
hsa-mir-133b esophageal squamous cell carcinoma down MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.
hsa-mir-133b esophageal squamous cell carcinoma down MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth.
hsa-mir-133b gastric cancer down miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.
hsa-mir-133b gastric cancer down MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.
hsa-mir-133b gastric cancer down MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
hsa-mir-133b gastric cancer down miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPAR? in gastric cancer.
hsa-mir-133b gastric cancer down The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
hsa-mir-133b gastric cancer down Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
hsa-mir-133b gastric cancer down MiR-133b inhibits growth of human gastric cancer cells by silencing PKM-splicer PTBP1.
hsa-mir-133b gastric cancer down MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.
hsa-mir-133b glioblastoma down MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.
hsa-mir-133b glioma down MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma.
hsa-mir-133b mir-133 glioma down Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.
hsa-mir-133b glioma down miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.
hsa-mir-133b glioma down miR-133b acts as a tumor suppressor and negatively regulates EMP2 in glioma.
hsa-mir-133b hepatocellular carcinoma down MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion Via Targeting LASP1 in Hepatocarcinoma Cells.
hsa-mir-133b hepatocellular carcinoma down Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
hsa-mir-133b mir-133 hepatocellular carcinoma down Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b hepatocellular carcinoma down MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
hsa-mir-133b mir-133 lung adenocarcinoma down miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.
hsa-mir-133b mir-133 lung cancer down Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
hsa-mir-133b lung cancer down MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.
hsa-mir-133b nasopharyngeal carcinoma down miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.
hsa-mir-133b non-small cell lung cancer down MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1.
hsa-mir-133b non-small cell lung cancer down miR-133b inhibits cell growth, migration, and invasion by targeting MMP9 in non-small cell lung cancer.
hsa-mir-133b osteosarcoma down Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.
hsa-mir-133b osteosarcoma down MicroRNA-133b inhibits cell proliferation and invasion in osteosarcoma by targeting to Sirt1.
hsa-mir-133b mir-133 prostate cancer down microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
hsa-mir-133b prostate cancer down Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
hsa-mir-133b renal cell carcinoma down cell lines; microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
hsa-mir-133b renal cell carcinoma down cell line; microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.